Canada’s Nutrien (TSX, NYSE: NTR), the world’s top potash producer, is reviewing its phosphate business as part of a strategy to simplify operations and boost long-term value.
The company said the review could lead to a reconfiguration of operations, new partnerships, or a potential sale. The move follows efforts to streamline Nutrien’s portfolio and strengthen free cash flow.
The phosphate division, valued at about $2.4 billion, according to RBC Capital Markets, is the smallest of Nutrien’s four business units. It generated $384 million in adjusted EBITDA in 2024, compared with more than $1.8 billion each from nitrogen and potash, and $1.7 billion from agricultural retail.
“We continue to progress our strategic initiatives and take actions to simplify our portfolio,” president and chief executive officer Ken Seitz said in a statement. He added that the changes aim to “enhance earnings…
